Hypertrophic cardiomyopathy: Clinical impact of a prolonged mHealth-based arrhythmia monitoring by single-channel ECG
Recruiting
- Conditions
- I42.1Obstructive hypertrophic cardiomyopathy
- Registration Number
- DRKS00032144
- Lead Sponsor
- niversitätsklinik für Kardiologie und Internistische Intensivmedizin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
Sufficient adherence as well as sufficient German language skills
- Ability to give consent
Exclusion Criteria
- Pre-existing cardiac implant (event recorder, pacemaker, ICD) or already indication for it
- Parkinson's disease with relevant tremor
- Incapacity to give consent
- current symptoms or a history of skin cancer, skin rash on skin glue, dermatosis
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of cardiac arrhythmias (nsVT, ventricular tachycardia of >3 beats to <30 sec with >120 bpm) in low- to intermediate-risk HCM patients* with additional mHealth-based prolonged rhythm monitoring.<br>Data collection is performed at the beginning of study participation (d=1) and for the following 14 days by ECG patch (d=1-14). This is followed by a telephone visit with discussion of the findings (d= approx. 20).
- Secondary Outcome Measures
Name Time Method - Number of patients who experience a change in therapeutic procedure (ICD implantation, antiarrhythmic drugs, etc.) due to detected nsVT in additional monitoring.<br>- Number of patients with detection of atrial fibrillation (duration >30 sec) by prolonged monitoring.<br>- Number of patients who experience a change in therapeutic procedure (anticoagulation, antiarrhythmic drugs, catheter ablation, etc.) due to detected atrial fibrillation<br>- Number of female patients who experience a change in therapeutic procedure due to prolonged monitoring.<br>- Prevalence of cardiac arrhythmias in patients with positive MRI findings (> 5% late gadolinium enhancement) <br>- Prevalence of cardiac arrhythmias in patients with positive genetic diagnosis (detection of HCM-typical gene variants)